Eli Lilly has turned to one of its Gateway Labs residents to help the Big Pharma develop trans-amplifying RNA (taRNA) vaccines for infectious diseases.
- Home |
- Lilly pens deal with Gateway Labs alumni Amplitude for RNA vaccine platform for infectious disease
Lilly pens deal with Gateway Labs alumni Amplitude for RNA vaccine platform for infectious disease
- August 20, 2026
Recent Posts
- LNG market tightens into winter as Europe pulls US cargoes, China reopens contract talks
- EIA: US crude oil inventories down 3.2 million bbl
- Chevron restructures Bakken midstream agreements, transfers Hess Midstream stake
- Cenovus to build oil sands business via Athabasca acquisition
- Centalion acquires Haynesville gas assets from Silver Hill
